Basic Information
Pheburane
Regulatory Information
EMEA/H/C/002500
Authorised
July 30, 2013
February 21, 2013
13
October 1, 2024
Company Information
the netherlands
Trapgans 5 1244 RL Ankeveen
Eurocept International B.V.
Active Substances Detail
EMA Resources
Detailed Information
Therapeutic Indication
### Therapeutic indication Treatment of chronic management of urea-cycle disorders.
Overview Summary
This is a summary of the European public assessment report (EPAR) for Pheburane. It explains how the Agency assessed the medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use Pheburane. For practical information about using Pheburane, patients should read the package leaflet or contact their doctor or pharmacist.